Plasmodium falciparum Subtilisin-Like Domain Containing Protein ((PfSDP) PF3D7_1105800), a Cross-Stage Antigen, Elicits Short-Lived Antibody Response Following Natural Infection with Plasmodium falciparum
Authors:
- Jonas Arnaud Kengne-OuafoJKJonas Arnaud Kengne-Ouafo
- Collins M Morang'ACMCollins M Morang'A
- Nancy K NyakoeNNNancy K Nyakoe
- Daniel DosooDDDaniel Dosoo
- Richmond TackieRTRichmond Tackie
- Joe MutungiJMJoe Mutungi
- Saikou Y BahSBSaikou Y Bah
- Lucas Amenga-EtegoLALucas Amenga-Etego
- Britta C. UrbanBUBritta C. Urban
- Gordon A. AwandareGAGordon A. Awandare
- Yaw AniwehYAYaw Aniweh
- Bismarck DinkoBDBismarck Dinko
Preprint
- 4 April 2025
- preprint
- Published by MDPI AG in Preprints.org
Abstract
With the increasing detection of artemisinin resistance to front-line antimalarials in Africa and notwithstanding the planned roll-out of RTS’S and R21 in Africa, the search for new vaccines with high efficacy remains an imperative. Towards this endeavor, we performed in silico screening to identify Plasmodium falciparum gametocyte stage genes that could be targets of protection or diagnosis. Through the analysis, we identified a gene, Pf3D7_1105800, coding for a Plasmodium falciparum subtilisin-like do-main-containing protein (PfSDP). Genetic diversity assessment revealed the Pfsdp gene to be relatively conserved across continents with signs of directional selection. Using RT qPCR and western blots, we observed that Pfsdp is expressed in all parasite developmental stages at the transcript and protein levels. Immunofluorescence assays found PfSDP protein colocalizing with PfMSP-1 and partially with Pfs48/45 at the asexual and sexual stages, respectively. Further, we demonstrated that anti-PfSDP peptide-specific antibodies inhibited erythrocyte invasion by 20-60% in a dose-dependent manner, suggesting that PfSDP protein might play a role in merozoites invasion. We also discovered that PfSDP protein is immunogenic in children from different endemic areas with antibody level increasing from acute infection to day 7 post-treatment, followed by a gradual decay. The limited effect of antibodies on erythrocyte invasion could imply that it might be more involved in other processes in the development of the parasite.Keywords
All Related Versions
- Version 1, 2025-04-04, Preprints
- Published version: Cells, 14 (15), 1184.
This publication has 51 references indexed in Scilit:
- Immunization with full-length Plasmodium falciparum merozoite surface protein 1 is safe and elicits functional cytophilic antibodies in a randomized first-in-human trialnpj Vaccines, 2020
- A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte InfectionCell Reports, 2018
- A Genome-wide CRISPR Screen in Toxoplasma Identifies Essential Apicomplexan GenesCell, 2016
- Paths to a malaria vaccine illuminated by parasite genomicsTrends in Genetics, 2015
- Proteases as regulators of pathogenesis: Examples from the ApicomplexaBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2012
- Human immune responses that reduce the transmission of Plasmodium falciparum in African populationsInternational Journal for Parasitology, 2011
- Expression ofPlasmodium falciparum3D7 STEVOR proteins for evaluation of antibody responses following malaria infections in naïve infantsParasitology, 2007
- A protein interaction network of the malaria parasite Plasmodium falciparumNature, 2005
- Commitment to sexual differentiation in the human malaria parasite, Plasmodium falciparumParasitology, 2000
- The distribution of Plasmodium falciparum in the peripheral blood and bone marrow of Gambian childrenTransactions of the Royal Society of Tropical Medicine and Hygiene, 1981